FDA Import Refusal 1FX-4781964-5/10002/1 — Cipla Limited

Cipla Limited — FEI 3007021905

The FDA refused shipment 1FX-4781964-5/10002/1 from Cipla Limited (India) on Sep 30, 2026. The refused product falls under Drugs and Biologics — CLOPIDOGREL BISULFATE (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Sep 30, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61LDA38 CLOPIDOGREL BISULFATE (ANTI-COAGULANT)
Charges
75